Mirapex (pramipexole) for Parkinson's
August 1997
The FDA just approved Mirapex (pramipexole) for Parkinson's. It's the first new drug for Parkinson's since Eldepryl (selegiline) was approved almost ten years ago.
Mirapex is a dopamine agonist...similar to Permax (pergolide) and Parlodel (bromocriptine).
Mirapex works at least as well as bromocriptine...and might cause fewer serious side effects. That's because Mirapex ISN'T an ergot derivative like Permax and Parlodel.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote